Tag: DrugLaunch

• 

  Glenmark Pharmaceuticals Launches Epinephrine Injection in the US, Secures CGT Exclusivity

  Glenmark Pharmaceuticals has launched a generic version of Epinephrine Injection in the US, providing a more affordable option for treating severe allergic reactions like anaphylaxis. This FDA-approved medication is bioequivalent to the branded version and comes with a 180-day Competitive Generic Therapy exclusivity, offering both cost savings and improved access to life-saving treatment.

• 

  Natco Pharma Secures Approval for Generic Everolimus Tablets for Oral Suspension in the U.S.

  Natco Pharma has received FDA approval for its generic version of Everolimus tablets for oral suspension (TFOS), providing a more affordable treatment option for patients with TSC-related SEGA. This approval marks a significant milestone in the generics market, offering greater access to a critical therapy for both adult and pediatric patients.